Meeting
2024 ASCO Breakthrough
A pan-tumor description of the genomic, transcriptomic, and immunological landscape of sodium-glucose cotransporter-2 (SGLT2) and association with clinical outcomes.
Authors
Heng Tan
University of Miami/Jackson Memorial Hospital, Miami, FL
Heng Tan , Samuel A. Kareff , Harris Benjamin Krause , Andrew Elliott , Stephen V. Liu , Patrick C. Ma , Fernando Gerchman , Bernardo Spiazzi , Emmanuel S. Antonarakis , Ari M. Vanderwalde , Milan Radovich , Gilberto Lopes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics
Sub Track
Omics for precision medicine
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 104)
DOI
10.1200/JCO.2024.42.23_suppl.104
Abstract #
104
Poster Bd #
C4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
First Author: Heng Tan
Poster
2024 ASCO Annual Meeting
Survival and mutational differences based on ESR1 and ESR2 expression in non-small cell lung cancer (NSCLC).
First Author: Robert Hsu
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunologic landscape in solid tumors expressing leukocyte immunoglobulin-like receptor B2 (LILRB2).
First Author: Sandra Jones
Poster
2023 ASCO Annual Meeting
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes.
First Author: Brian Warnecke